Barclays has revised its price target for MetLife (MET, Financial), reducing it from $95 to $88, while maintaining an Overweight rating on the stock. This adjustment comes ahead of MetLife's first-quarter earnings announcement, as the insurance sector faces a challenging landscape.
In its analysis, Barclays highlights the difficulties in life earnings, emphasizing a preference for group benefits and the company's robust capital position. Additionally, the firm notes the attractive nature of the company's cash flows, which it describes as "cheap." Despite the sector's current uncertainties, these factors contribute to Barclays' continued confidence in MetLife's potential performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 12 analysts, the average target price for MetLife Inc (MET, Financial) is $94.92 with a high estimate of $110.00 and a low estimate of $73.00. The average target implies an upside of 33.48% from the current price of $71.11. More detailed estimate data can be found on the MetLife Inc (MET) Forecast page.
Based on the consensus recommendation from 17 brokerage firms, MetLife Inc's (MET, Financial) average brokerage recommendation is currently 2.1, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for MetLife Inc (MET, Financial) in one year is $91.15, suggesting a upside of 28.18% from the current price of $71.11. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the MetLife Inc (MET) Summary page.
